Seizert Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.1M | Buy |
85,980
+3,308
| +4% | +$1.74M | 1.98% | 22 |
|
|
2025
Q1 | $52.4M | Buy |
82,672
+28,368
| +52% | +$18M | 2.4% | 11 |
|
|
2024
Q4 | $38.7M | Buy |
54,304
+8,529
| +19% | +$6.08M | 1.75% | 26 |
|
|
2024
Q3 | $48.1M | Sell |
45,775
-6,185
| -12% | -$6.5M | 2.17% | 12 |
|
|
2024
Q2 | $54.6M | Sell |
51,960
-4,354
| -8% | -$4.58M | 2.71% | 8 |
|
|
2024
Q1 | $54.2M | Buy |
56,314
+543
| +1% | +$523K | 2.5% | 10 |
|
|
2023
Q4 | $49M | Sell |
55,771
-3,024
| -5% | -$2.66M | 2.48% | 9 |
|
|
2023
Q3 | $48.4M | Buy |
58,795
+1,323
| +2% | +$1.09M | 2.56% | 10 |
|
|
2023
Q2 | $41.3M | Sell |
57,472
-966
| -2% | -$694K | 2.21% | 13 |
|
|
2023
Q1 | $48M | Sell |
58,438
-4,288
| -7% | -$3.52M | 2.64% | 9 |
|
|
2022
Q4 | $45.3M | Sell |
62,726
-8,752
| -12% | -$6.31M | 2.4% | 8 |
|
|
2022
Q3 | $49.2M | Sell |
71,478
-13,823
| -16% | -$9.52M | 2.78% | 4 |
|
|
2022
Q2 | $50.4M | Buy |
85,301
+3,696
| +5% | +$2.18M | 2.67% | 6 |
|
|
2022
Q1 | $57M | Sell |
81,605
-5,757
| -7% | -$4.02M | 2.62% | 4 |
|
|
2021
Q4 | $55.2M | Sell |
87,362
-1,737
| -2% | -$1.1M | 2.47% | 6 |
|
|
2021
Q3 | $53.9M | Buy |
89,099
+2,037
| +2% | +$1.23M | 2.47% | 8 |
|
|
2021
Q2 | $48.6M | Buy |
87,062
+2,485
| +3% | +$1.39M | 2.32% | 9 |
|
|
2021
Q1 | $40M | Buy |
84,577
+35,991
| +74% | +$17M | 2.09% | 13 |
|
|
2020
Q4 | $23.5M | Buy |
48,586
+12,852
| +36% | +$6.21M | 1.37% | 31 |
|
|
2020
Q3 | $20M | Sell |
35,734
-711
| -2% | -$398K | 1.31% | 34 |
|
|
2020
Q2 | $22.7M | Sell |
36,445
-4,033
| -10% | -$2.52M | 1.54% | 29 |
|
|
2020
Q1 | $19.8M | Sell |
40,478
-26,381
| -39% | -$12.9M | 1.46% | 30 |
|
|
2019
Q4 | $25.1M | Sell |
66,859
-9,228
| -12% | -$3.46M | 1.25% | 33 |
|
|
2019
Q3 | $21.1M | Buy |
+76,087
| New | +$21.1M | 1.06% | 37 |
|